De novo synthesis is the main pathway for cancer cells to produce fatty acids (FAs); FA synthase (FASN) is highly expressed in various cancers including lung cancer and low production of FASN in NSCLC patients have longer survival [5–7]. The gene discussed is FASN; the disease is non-small cell lung carcinoma.